NNRX Stock Overview
Nutranomics, Inc. engages in the research, development, and sale of nutritional food products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Nutranomics, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -99.00% |
| 3 Year Change | -99.91% |
| 5 Year Change | -99.86% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| NNRX | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | -0.5% | 2.0% |
| 1Y | -99.0% | -28.0% | 22.3% |
Return vs Industry: NNRX underperformed the US Personal Products industry which returned -28% over the past year.
Return vs Market: NNRX underperformed the US Market which returned 22.3% over the past year.
Price Volatility
| NNRX volatility | |
|---|---|
| NNRX Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NNRX has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NNRX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | n/a | Jonathan Bishop | www.nutranomics.com |
Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company provides Nutritional Blood Analysis, a tool to examine the customer’s blood cells on a video monitor, live, in real time; and the patented Assimilation Enhancing System that improves the absorption of nutrients.
Nutranomics, Inc. Fundamentals Summary
| NNRX fundamental statistics | |
|---|---|
| Market cap | US$16.75k |
| Earnings (TTM) | US$25.93k |
| Revenue (TTM) | n/a |
0.0x
P/E Ratio0.0x
P/S RatioIs NNRX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NNRX income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | -US$25.93k |
| Earnings | US$25.93k |
Last Reported Earnings
Apr 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did NNRX perform over the long term?
See historical performance and comparison